Apogee Therapeutics, Inc. Deferred Offering Costs
Apogee Therapeutics, Inc. (APGE) had Deferred Offering Costs of $0 as of 2023-12-31, per its 10-K filed 2024-03-05.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2024-03-05
- 2023-12-31: Deferred Offering Costs $0.00.
- 2023-09-30: Deferred Offering Costs $200.00K.
- 2023-06-30: Deferred Offering Costs $3.47M.
- 2022-12-31: Deferred Offering Costs $0.00.
| Period end | Deferred Offering Costs |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-05 |
| 2023-09-30 | $200.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $3.47M 10-Q · filed 2023-08-28 |
| 2022-12-31 | $0.00 10-Q · filed 2023-08-28 |